Unlock instant, AI-driven research and patent intelligence for your innovation.

Composition for detecting esophageal cancer

A composition and technology for esophageal cancer, applied in the biological field, can solve the problems of high cost, inconvenient detection, low sensitivity and the like, and achieve the effects of effective detection and good detection sensitivity

Active Publication Date: 2020-03-06
BIOCHAIN BEIJING SCI & TECH
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Based on this, aiming at the problems of inconvenient detection, low sensitivity and high cost in existing esophageal cancer detection technology, the present invention provides a composition for detecting esophageal cancer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition for detecting esophageal cancer
  • Composition for detecting esophageal cancer
  • Composition for detecting esophageal cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0227] By analyzing the data of 233 cases of esophageal cancer tissues and 171 cases of normal esophagus tissues, the genome-wide methylation chip (Illumina's HumanMethylation450k chip) data, the inventors found that the methylation levels of MT1A gene and EPO gene in esophageal cancer tissues were significantly higher in normal esophageal tissue (analysis results such as figure 1 shown). Furthermore, the present inventors found that the two target genes were significantly different in esophageal cancer tissue and normal esophagus tissue by analyzing the probe sequences of MT1A gene and EPO gene on the genome-wide methylation chip and the corresponding methylation rate data. The sequence fragments with the most obvious difference in methylation were identified as the target sequences of the two target genes.

[0228] The target sequence of MT1A gene is shown in SEQ ID NO:1.

[0229] SEQ ID NO:1

[0230] CACCCAGGGGAGCTCAGTGGACTGTGCGCCTTGCCTTTCTGCTGCGCAAAGCCCAGTCCAGGTCATCACCT...

Embodiment 2

[0241] Step 1: Obtain the DNA of the biological sample to be analyzed. The source may be any suitable source, such as cell lines, histological sections, biopsies, paraffin-embedded tissues, body fluids, feces, urine, plasma, serum, whole blood, isolated blood cells, cells isolated from blood, and all possible combinations. DNA is then isolated from the sample by any standard means known in the art. Briefly, when DNA is enclosed in cell membranes, the biological sample must be disrupted and lysed by enzymatic, chemical or mechanical means. Proteins and other contaminants are subsequently removed, eg, by protein kinase K digestion. The DNA is then recovered from the solution. This can be achieved by various methods including salting out, organic extraction or binding the DNA to a solid support. The choice of method will be influenced by several factors, including time, cost, and the amount of DNA required. When the sample DNA is not encapsulated in cell membranes (eg, circu...

Embodiment 3

[0274] According to a specific embodiment of the present application, based on the average Ct value of the detection results of a certain number of esophageal cancer samples and normal samples, the Ct value of the target gene that can effectively distinguish esophageal cancer and normal samples is determined, that is, the critical value. The methylation status of at least one CpG dinucleotide of the target gene target sequence is determined by the cycle threshold Ct value of the polymerase chain reaction. By comparing the Ct value of the measured sample with the preset critical value, it is determined that the Whether the gene analysis is negative (normal) or positive (esophageal cancer).

[0275] This embodiment includes the following steps:

[0276] First, plasma samples from 20 patients with esophageal cancer and 22 normal individuals were obtained. All samples come from Boercheng Company. Then extract the free peripheral blood DNA of the test sample, and pretreat the DNA...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a composition for detecting the esophageal cancer. The composition comprises nucleic acid for detecting the methylation state of a target gene and an antibody for detecting theconcentration of a target protein. The target gene is one or two of an MT1A gene and an EPO gene; and the target protein is SNCG. In addition, the invention also provides a kit comprising the composition as well as application of the composition in preparation of a kit for in-vitro detection of the esophageal cancer.

Description

technical field [0001] The invention belongs to the field of biotechnology and relates to a composition and its use in disease detection, in particular to a composition for detecting esophageal cancer and its corresponding kit and use. Background technique [0002] Esophageal cancer is a common digestive tract tumor. According to data from the National Cancer Prevention Office, in 2015, the incidence of esophageal cancer in China was 478 cases per 100,000 people, and the death rate was 375 cases per 10,000 people, ranking fourth and third among common cancers respectively. The fatality rate of esophageal cancer is close to 80%, and it is a kind of cancer with high malignant degree. About 300,000 people die from esophageal cancer every year in the world, half of which come from China. [0003] An important factor leading to the high mortality rate of esophageal cancer is the low diagnosis rate of early esophageal cancer. The cure rate of early esophageal cancer is much hig...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/6886G01N33/574C12N15/11
CPCC12Q1/6886G01N33/57407C12Q2600/154G01N33/57484
Inventor 马竣韩晓亮王建铭
Owner BIOCHAIN BEIJING SCI & TECH